02.01.2015 Views

Adnexal Masses in Pregnancy - Cmebyplaza.com

Adnexal Masses in Pregnancy - Cmebyplaza.com

Adnexal Masses in Pregnancy - Cmebyplaza.com

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

James M. Shwayder, M.D., J.D.<br />

Associate Professor<br />

University of Louisville SOM<br />

Director: Division i i of Gynecology<br />

Director: Fellowship <strong>in</strong> M<strong>in</strong>imally Invasive Surgery<br />

Louisville, Kentucky


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

James M. Shwayder, MD, JD<br />

Disclosures:<br />

• Cook OB-Gyn:<br />

• Philips Ultrasound:<br />

• Ethicon EndoSurgery:<br />

Honorarium, Royalties<br />

Honorarium<br />

Honorarium, Fellowship Support


Objectives<br />

• Discuss the use of ultrasound <strong>in</strong><br />

adnexal evaluation dur<strong>in</strong>g pregnancy<br />

• Diagnosis<br />

• Patient counsel<strong>in</strong>g<br />

• Procedure plann<strong>in</strong>g<br />

• Case examples


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

• Age<br />

• Morphology<br />

• Doppler<br />

• Tumor markers


Age Related Risk of Malignancy of<br />

an Ovarian Tumor (959 Patients)<br />

Malignant<br />

Benign<br />

Age, Yrs N % N % RM (%) RR<br />

< 20 14 5 446 24.1 29<br />

2.9<br />

21 - 30 12 4 132 19 8.3 1.0<br />

31 - 40 21 8 138 20 13.2 1.6<br />

41 - 50 42 16 180 15 43.3 2.3<br />

51 - 60 81 30 106 15 43.3 5.2<br />

61 - 70 68 25 56 8 54.8 66<br />

6.6<br />

> 71 33 12 32 5 50.8 6.1<br />

Rate of malignancy (RM)<br />

Relative Risk of malignancy (PR)<br />

M<strong>in</strong>aretzis et al. Gynecol Obstet Invest 1994; 38, 140-144144


Morphology<br />

Differentiat<strong>in</strong>g Benign from Malignant Ovarian<br />

Lesions<br />

Author n PPV<br />

NPV<br />

Sens<br />

Spec<br />

Koboyashi (1976) 406 31 93 71 73<br />

Meire et al (1978) 51 83 91 83 91<br />

Pussell et al (1980) 25 83 91 83 84<br />

Hermann et al (1987) 241 75 95 82 93<br />

F<strong>in</strong>kler et al (1988) 102 88 81 62 95<br />

Benacerraf et al (1990) 100 72 91 80 87<br />

Granburg et al (1990) 180 74 95 82 92<br />

Sassone et al (1991) 143 37 100 100 83


Color Flow Doppler<br />

• Significant ifi overlap <strong>in</strong> blood flow<br />

patterns between pregnancy<br />

and malignancy<br />

• False positive rate ~ 50%<br />

Wheeler and Fleischer. J Ultrasound Med 1997;16:425-28.<br />

28.


Tumor Markers<br />

• CA125 Epithelial ovarian cancer (80%)<br />

• CA 19-9<br />

• AFP<br />

Exception: muc<strong>in</strong>ous tumors<br />

Muc<strong>in</strong>ous tumors<br />

Germ cell tumors<br />

Endodermal s<strong>in</strong>us tumor<br />

• β-hCG<br />

Germ cell tumors<br />

Choriocarc<strong>in</strong>oma<br />

• LDH<br />

Dysgerm<strong>in</strong>oma


26 y.o. G2P1001<br />

• Ultrasound for early dat<strong>in</strong>g<br />

• Poor dates


26 y.o. G2P1001 at 9w4d


RI = 0.81<br />

PI = 2.27


26 y.o. G2P1001 at 9w4d<br />

US for early dates<br />

• S<strong>in</strong>gle, viable IUP<br />

• CRL =2.8 cm c/w 9w4d<br />

• Right ovary: Corpus luteum 1.9 x1.5 cm<br />

• Left ovary: 13.23 x 12.19 x 9.91 cm cyst,<br />

unilocular with <strong>in</strong>ternal echoes, a th<strong>in</strong><br />

septation and wall nodularity.


26 y.o. G2P1001 at 9w4d<br />

• Probable diagnosis<br />

• Serous or muc<strong>in</strong>ous cystadenoma<br />

• Should we operate<br />

• Let’s talk


RISKS TO THE<br />

MOTHER<br />

RISKS TO THE<br />

PREGNANCY


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Why operate<br />

• Possible malignancy<br />

• Prevent <strong>com</strong>plications<br />

• Torsion<br />

• Rupture<br />

• Obstruction of labor


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Risks of Surgery<br />

• Spontaneous miscarriage<br />

i<br />

• Rupture of membranes<br />

• Preterm labor<br />

• Preterm birth


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

• 1-4 % of pregnant women are diagnosed with<br />

an adnexal mass 1,2<br />

• 82% 3 to 94% 4 rate of spontaneous resolution<br />

1 Hill et al. Am J Obstet Gynecol 1998; 179: 703-707. 707.<br />

2<br />

Nelson et al. J Cl<strong>in</strong> Ultrasound 1986; 14: 509-512.<br />

512.<br />

3 Thornton and Wells. Obstet Gynecol 1987;69:717-21.<br />

4 Grimes et al. Am J Obstet Gynecol 1954;68:594-605. 605.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

• 82% 1 to 94% 2 rate of spontaneous resolution<br />

• Particularly simple, unilocular cysts<br />

• Most of the others are a corpus luteum and<br />

resolve by 16 weeks<br />

• Expectant management is appropriate for<br />

adnexal masses < 6 cm <strong>in</strong> the first trimester 1,2<br />

1 Thornton and Wells. Obstet Gynecol 1987;69:717-21.<br />

2 Grimes et al. Am J Obstet Gynecol 1954;68:594-605. 605.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

• 1–8% of persistent masses are malignant<br />

• Traditionally, most masses were treated by<br />

laparotomy at 16-20 weeks of gestation<br />

Whitecar et al. Am J Obstet Gynecol 1999;181:19-24.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Surgery vs. Observation<br />

• Retrospective review of 127,177<br />

deliveries i between 1999 – 2003<br />

• <strong>Adnexal</strong> mass > 5 cm <strong>in</strong> 63 (0.05%)<br />

• Pathology available <strong>in</strong> 59 (94%)<br />

• Lost to follow-up: 4<br />

• Antepartum surgery: 17 (29%)<br />

• Postpartum surgery: 42 (71%)<br />

Schmeler et al. Obstet Gynecol 2005; 105: 1098-1103. 1103.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Antepartum Surgery (n = 17)<br />

• Suspicion of malignancy 13 (76.5%)<br />

• Mixed cystic and solid <strong>com</strong>ponents<br />

• Septations<br />

• Papillary projections<br />

• Wall nodularity<br />

• Emergency surgery for torsion 4 (23.5%)<br />

• 68%of59masses<br />

6.8 • Surgery at 9, 13, 25, 34 weeks of gestation<br />

• PPROM at 23 w chorioamnionitis<br />

Schmeler et al. Obstet Gynecol 2005; 105: 1098-1103. 1103.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Pathologic diagnosis i (n=59)<br />

Pathologic Diagnosis # %<br />

Dermoid 25 42.3<br />

Functional cyst 9 15.3<br />

Cystadenoma 9 15.3<br />

Adenofibroma 3 50 5.0<br />

Fibroid 4 6.8<br />

Malignancy 4 68 6.8<br />

Endometrioma 3 5.1<br />

Borderl<strong>in</strong>e tumor (LMP) 1 17 1.7<br />

Resolution of mass 1 1.7


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Pathologic diagnosis i (7 studies)<br />

Pathologic Diagnosis %<br />

Dermoid 25<br />

Functional cyst, paraovarian 17<br />

Serous cystadenoma 14<br />

Muc<strong>in</strong>ous cystadenoma 11<br />

Endometrioma 8<br />

Malignancy 28 2.8<br />

Borderl<strong>in</strong>e tumor (LMP) 3<br />

Leiomyoma 2<br />

Hoover and Jenk<strong>in</strong>s.Am<br />

JObstet<br />

Gynecol 2011;205(2):97-102.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Study<br />

AP<br />

Surgery<br />

Malignancy<br />

% Cancer LMP<br />

Complications<br />

SAB<br />

Torsion<br />

Bernard 1988-1993 79 0 3.1 NA 3.1<br />

Platek 1988-1994 59 0 0 3.2 0<br />

Bromley 1988-1995 19 0.8 0 0 0.8<br />

Whitecar 1989-1994 66 3.1 3.1 1.5 5.4<br />

Sherard 1990-2002 55 5.0 8.3 4.7 1.8<br />

Schmeler 1990-2003 27 6.8 1.7 0 6.8<br />

Yen 1990-2004 44 2.3 3.4 14.8


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Risk of Malignancy<br />

Size Matters


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Risk Malignancy<br />

• Retrospective review of 1990-2002<br />

• 60 patients (0.15% of pregnancies)<br />

• EGA at diagnosis<br />

12 weeks<br />

• EGA at surgery<br />

20 weeks<br />

• Malignancy (CA + LMP) 13.3%<br />

• % CA 3 37% 5.0%<br />

• % LMP 5 63% 8.3%<br />

Sherard et al. Am J Obstet Gynecol 2003;189:358-63.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Risk of Malignancy<br />

Category<br />

Size<br />

Malignant<br />

11.5 cm<br />

Benign<br />

7.6 cm<br />

Sherard et al. Am J Obstet Gynecol 2003;189:358-63.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Risk of Malignancy<br />

Size<br />

> 10 cm<br />

Growth > 0.35 cm/week<br />

Odds of Malignancy<br />

11.2<br />

8.77% vs 0.85%<br />

10.2<br />

8.33% vs 0.88%<br />

Yen et al. Fertil Steril 2009;91:1895-1902. 1902.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Risk Analysis of Torsion and Malignancy<br />

• Retrospective review of 1990-2004<br />

• 213 patients<br />

t<br />

• 174 were followed dur<strong>in</strong>g pregnancy<br />

with ithakno known nt tumor<br />

• Torsion 24 13.8%<br />

• Ovarian cancer 4 23%<br />

2.3%<br />

• Malignancy (CA+LMP) 6 3.4%<br />

Yen et al. Fertil Steril 2009;91:1895-1902. 1902.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Risk of Torsion - Size<br />

Size<br />

All<br />

Patients<br />

Known<br />

tumors<br />

Overall 14.8% 13.8%<br />

5-10 cm 69.7%<br />

6-8 cm 51.5% 22.4%*<br />

*<strong>com</strong>pared to 9.6% for tumors of other sizes<br />

Yen et al. Fertil Steril 2009;91:1895-1902.<br />

1902.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Risk of Torsion<br />

• No difference<br />

• Age<br />

• Parity<br />

• Right = Left<br />

• Size <strong>in</strong> known and unknown<br />

tumors that undergo torsion<br />

Yen et al. Fertil Steril 2009;91:1895-1902. 1902.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Risk of Torsion - EGA<br />

Gestational Age<br />

Percentage of<br />

torsions<br />

10-17 weeks 60.0%<br />

15-16 weeks 36.7%<br />

> 20 weeks 5.9%<br />

Yen et al. Fertil Steril 2009;91:1895-1902. 1902.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Surgical Complications<br />

Laparotomy at 16-20 weeks (n=60)<br />

Category<br />

Percentage<br />

Preterm Birth Rate 9%<br />

Miscarriage Rate 4.7%<br />

Sherard et al. Am J Obstet Gynecol 2003;189:358-63.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Surgical Complications<br />

Laparotomy at 6-41 weeks (n=34)<br />

Category<br />

(Surgery <strong>in</strong> 2 nd Trimester)<br />

Percentage<br />

Preterm Birth Rate 58% 5.8%<br />

Miscarriage Rate 2.9%<br />

Balci et al. J Obstet Gynaecol Res. 2008;34:524-28. 28.


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Surgical Complications<br />

Laparoscopy py<br />

2 ND Trimester<br />

Author<br />

Miscarriage<br />

PPROM<br />

Preterm Labor<br />

Yeun and Chang 1<br />

n=6<br />

Tazuke et al. 2<br />

n=9<br />

Stepp et al.<br />

3<br />

n=11<br />

0% 0% 0%<br />

0% 11.1% 0%<br />

0% 0% 0%<br />

1 Yuen and Chang. Acta Obstet Gynecol Scand 1997;76:173-76.<br />

76.<br />

2 Tazuke et al. J Am Assoc Gynecol Laparosc 1997;4(5):605-608. 608.<br />

3 Stepp et al. J Am Assoc Gynecol Laparosc 2003;10(1):55-59. 59.


26 y.o. G2P1001 at 13 weeks<br />

• Probable bl diagnosis<br />

i<br />

• Serous or muc<strong>in</strong>ous cystadenoma<br />

• Should we operate<br />

• Yes<br />

• Laparoscopy v. Laparotomy<br />

• Surgeon dependant d 123<br />

1,2,3<br />

1. Moore and Smith. J Reprod Med. 1999; 44: 97-100.<br />

2. Parker et al. Am J Obstet Gynecol. 1996: 174; 1499-15011501<br />

3. Roman et al. J M<strong>in</strong> Invasive Gynecol. 2005; 21: 377-78. 78.


26 y.o. G2P1001 at 13 weeks<br />

• L/S left salp<strong>in</strong>goophorectomy<br />

• Serous cystadenoma of LMP<br />

• No <strong>com</strong>plications<br />

• Delivered at term


21 y.o. G1P0<br />

• LMP = unknown<br />

• Exam: Palpable cul-de<br />

de-sac<br />

mass<br />

• No FHT’s by Doppler


FHR = 160 bpm


OUTCOME<br />

• Resolved spontaneously<br />

• Probable luteal cysts


22 y.o. G1P0<br />

• Enters c/o abdom<strong>in</strong>al pa<strong>in</strong><br />

• EGA ~ 5 weeks


22 y.o. G1P0<br />

• Laparoscopy<br />

• Torsion – right ovary<br />

• Dermoid


24 y.o. G2P1001<br />

• Presents for ultrasound<br />

• Unknown dates


RIGHT OVARY


PI = 0.93<br />

RI = 0.57


24 y.o. G2P1001<br />

• Laparoscopy<br />

• Post-partum<br />

• Bilateral ovarian cystectomies<br />

• Dermoids


26 y.o. G1P0<br />

13w4d


26 yo y.o. G1P0<br />

13w4d<br />

• LSO<br />

• Right ovarian cystectomy<br />

• Bilateral endometriomas, the<br />

right was decidualized


40 y.o. G2P1001<br />

13w2d<br />

• Ultrasound for <strong>com</strong>plex mass on<br />

first trimester study


13w2d


13w2d


13w2d


13w2d


13w2d


40 y.o. G2P1001<br />

13w2d<br />

• Laparoscopic p<br />

LSO<br />

• Dermoid


28 y.o. G3P2002<br />

• Rout<strong>in</strong>e ultrasound for dat<strong>in</strong>g<br />

• 14w5d


RI = 0.73


Color Flow Doppler<br />

• Significant ifi overlap <strong>in</strong> blood flow<br />

patterns between pregnancy<br />

and malignancy<br />

• False positive rate ~ 50%<br />

Wheeler and Fleischer. J Ultrasound Med 1997;16:425-28. 28.


28 y.o. G3P2002<br />

History<br />

• Prior laparotomy<br />

• Stage III-B Serous tumor LMP<br />

• Elected on observation


28 y.o. G3P2002<br />

• Vag<strong>in</strong>al delivery at term<br />

• F<strong>in</strong>al stag<strong>in</strong>g g post-partumpartum<br />

• Serous tumor of LMP<br />

• No evidence of metastasis


37 y.o. G4P3003<br />

• Referred ee ed for adnexal a<br />

mass<br />

identified on ultrasound at<br />

planned amniocentesis<br />

• US EGA = 15w3d


37 y.o. G4P3003<br />

15w3d


37 y.o. G4P3003<br />

23w2d


23w2d


23w2d


23w2d


23w2d


23w2d


37 y.o. G4P3003<br />

26w2d


26w2d


26w2d


26w2d


26w2d


37 y.o. G4P3003<br />

34w2d


34w2d


34w2d


34w2d


37 y.o. G4P3003<br />

• Cesarean delivery at 39 wks<br />

• Left salp<strong>in</strong>go-oophorectomy<br />

oophorectomy<br />

• Frozen: Cannot rule-out borderl<strong>in</strong>e<br />

tumor<br />

• Permanent: Serosal endometriosis<br />

and a serous tumor of LMP


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Summary<br />

• 82%-94% of masses detected t d <strong>in</strong><br />

the 1 st trimester resolve<br />

spontaneously<br />

• Observation is appropriate with<br />

masses < 6 cm <strong>in</strong> size


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Summary-Malignancy<br />

Of those that persist<br />

• Risk of malignancy 1-7%<br />

• CA + LMP 1-13% 13%<br />

• Risk greatest<br />

• Size > 10 cm<br />

• Growth > 1 cm <strong>in</strong> 3 weeks


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Summary-Torsion<br />

• Risk of torsion 1-15% 15%<br />

• 5-10 cm 69%<br />

• Tim<strong>in</strong>g go of toso<br />

torsion<br />

• 10-1717 weeks 60%<br />

• 15-1616 weeks 39%<br />

• > 20 weeks 6%


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Summary<br />

Surgical risks (at laparotomy)<br />

• Preterm Birth Rate 9%<br />

• Miscarriage Rate 4.7%<br />

• These risks are reduced with<br />

laparoscopy


<strong>Adnexal</strong> <strong>Masses</strong> <strong>in</strong> <strong>Pregnancy</strong><br />

Indications for Surgery<br />

• Strong suspicion for malignancy<br />

• Increased risk of<br />

torsion/rupture/obstruction <strong>in</strong> labor<br />

• Symptomatic<br />

ti


Thank You

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!